Church & Dwight reported a 5.7% increase in net sales for Q4 2021, reaching $1,368.7 million. EPS increased by 8.5% to $0.64 per share, and adjusted EPS grew by 20.8%. Organic sales grew by 4.3%.
Net sales increased by 5.7%, driven by growth in domestic, international, and specialty products divisions.
Organic sales grew by 4.3%, exceeding the company's outlook.
EPS increased by 8.5% to $0.64 per share, with adjusted EPS growth of 20.8%.
The company closed on the THERABREATH® acquisition in late December, expecting $100 million in sales for 2022.
The Company expects full year 2022 reported sales growth to be approximately 5%-8% and organic sales growth to be approximately 3%-6%. We estimate full year EPS of $3.14 to $3.26, an increase of 4%-8% compared to prior year adjusted EPS.
Visualization of income flow from segment revenue to net income